XM does not provide services to residents of the United States of America.
L
L

Lonza


News

AB Dynamics, Etteplan, Wise

EUROPE RESEARCH ROUNDUP-AB Dynamics, Etteplan, Wise June 14 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AB Dynamics, Etteplan and Wise, on Friday. HIGHLIGHTS * AB Dynamics Plc ABDP.L : Berenberg re-initiates coverage With Buy rating; PT 2,620p * Crest Nicholson CRST.L : Barclays cuts target price to 230p from 258p * Etteplan Oyj ETTE.HE : Evli Research raises to buy from hold * Halma HLMA.L : Barclays raises target price to 284
B
C
E
H
H
J
L
O
O
P
R
S
S
T
U
V
V
Z
H
A
R

Asmi, Beiersdorf, SSE

EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Asmi, Beiersdorf and SSE, on Friday. HIGHLIGHTS * Arcadis NV ARDS.AS : KBC Securities raises to accumulate from buy * Asmi ASMI.AS : Berenberg raises target price to EUR 720 from EUR 640 * Beiersdorf BEIG.DE : HSBC raises target price to EUR 158 from EUR 152 * Nibe Industrier AB NIBEB.ST : HSBC cuts to hold from buy * SSE SSE.L : HS
A
B
B
C
D
E
E
I
J
L
L
S
W

Asmi, Beiersdorf, SSE

CORRECTED-EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE Corrects Greenyard NV entry to say KBC Securities raises target price to EUR 9.5 from EUR 8.5 (not 6.30) and Arcadis NV entry to say KBC Securities cuts (not raises) to 'accumulate' from 'buy'; raises target price to EUR 66 from EUR 61 (not 61.7 June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Asmi, Beiersdorf and SSE, on Friday.
A
B
B
B
C
D
D
E
E
I
J
K
L
L
P
R
S
V
V
V
W
P
S

Swiss pharma supplier Lonza reports softer Q1 but confirms outlook

UPDATE 1-Swiss pharma supplier Lonza reports softer Q1 but confirms outlook Adds outlook in paragraph 1, info about Biosecure Act in paragraph 5-6, CFO quote in paragraph 7 By Chiara Holzhaeuser and Tristan Veyet May 14 (Reuters) - Swiss pharmaceutical supplier Lonza LONN.S reported a "softer Q1" on Tuesday, while confirming its 2024 outlook, saying its lacklustre performance was mainly due to the phasing of commercial batches and a weaker start at its bioscience business.
B
L

Swiss pharma supplier Lonza flags signs of recovery in biotech funding

Swiss pharma supplier Lonza flags signs of recovery in biotech funding May 14 (Reuters) - Swiss pharmaceutical supplier Lonza LONN.S confirmed its 2024 outlook on Tuesday, flagging early signs of recovery in biotech funding even as clinical demand in its biologics division remained soft in the first quarter. It said commercial performance was positive across its biologics, small molecules, and cell & gene businesses in the quarter, while development in its capsules & health ingredients unit was
B
L

Lonza Group Confirms 2024 Outlook

BRIEF-Lonza Group Confirms 2024 Outlook May 14 (Reuters) - LONZA GROUP AG LONN.S : PERFORMANCE IN LINE WITH EXPECTATIONS FOR FULL-YEAR 2024 H2 SALES EXPECTED TO BE SOLID CONFIRMS OUTLOOK 2024 Source text for Eikon: ID:nSN6xhSvm Further company coverage: LONN.S (Gdansk Newsroom)
L

Swiss stocks - Factors to watch on May 14

Swiss stocks - Factors to watch on May 14 ZURICH/BERLIN, May 14 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: UBS UBSG.S UBS CEO Sergio Ermotti warned on Monday that any delay to the integration of its technology and data with those of former rival Credit Suisse would erode planned cost savings, as he vowed to see the process through and stay on until 2027. GLENCORE GLEN.L Australia's Queensland state will decide this month whether to give Glencore a key
A
G
L
S
S
U

Swiss stocks - Factors to watch on May 13

Swiss stocks - Factors to watch on May 13 ZURICH/BERLIN, May 13(Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday: NESTLE NESN.S Media/Bloomberg - PAI to delay exit from 10 million dollar ice cream joint venture. KL 1 Together with the German aviation firm Lilium 5KD.F , the company will set up new sites in France in a combined investment of 700 million euros.
A
L
N
S
S

Adecco Group, Centrica, UBS

EUROPE RESEARCH ROUNDUP-Adecco Group, Centrica, UBS May 8 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adecco Group, Centrica and UBS, on Wednesday. HIGHLIGHTS * Adecco Group AG ADEN.S : RBC raises to outperform from sector perform * Centrica CNA.L : UBS raises to buy from neutral * Direct Line Insurance DLGD.L : Morgan Stanley resumes coverage with equal-weight rating * Lindt & Spruengli LISN.S : Barclays raises to equal weight
A
A
A
A
A
A
B
B
B
B
B
C
D
E
G
H
H
I
K
L
L
L
S
S
S
V
A
A
B
B
D
D
M

Swiss stocks - Factors to watch on May 8

Swiss stocks - Factors to watch on May 8 ZURICH/BERLIN, May 8(Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday: COMPANY STATEMENTS * Talenthouse THAGN.S - Postponement Of Publication Of The Annual Report 2023 Until 31 May 2024 * EDAG Engineering Group ED4.DE - Harald Keller Appointed CEO As Of July 01, 2024 * Garrett Motion G02.F - Upsizing And Pricing Of Private Offering Of $800 Million Of Senior Notes Due 2032 ANNUAL GENERAL MEETINGS ALCON AG ALCC.S - 0.24
A
K
L
S

Roche to review manufacturing further after sale of site to Lonza, CEO says

Roche to review manufacturing further after sale of site to Lonza, CEO says FRANKFURT, April 24 (Reuters) - Roche ROG.S will further review its manufacturing network after the sale of a major site to Lonza LONN.S last month because biotech production technology has become much more efficient. Speaking after the release of quarterly sales, CEO Thomas Schinecker said the Swiss group has the largest manufacturing capacity in the pharma industry and it needs to adapt because technology upgrades in s
L
R

Swiss stocks - Factors to watch on April 18

Swiss stocks - Factors to watch on April 18 ZURICH/BERLIN, Apr 18(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: UBS AG UBSG.S UBS Group is planning another round of job cuts after its takeover of Credit Suisse that is expected to affect over a hundred positions across the group's global investment bank, Bloomberg News reported on Wednesday.
A
L
N
S
U

Lonza Prices EUR 1 Bln Straight Bond With 3.875% Coupon

BRIEF-Lonza Prices EUR 1 Bln Straight Bond With 3.875% Coupon April 17 (Reuters) - Lonza Group AG LONN.S : LONZA PRICES EUR 1 BILLION STRAIGHT BOND WITH A 3.875% COUPON BOND HAS A MATURITY OF 12 YEARS AND AN ANNUAL COUPON OF 3.875% Source text for Eikon: ID:nEQ4MCSfYa Further company coverage: LONN.S
L

Fujifilm to invest $1.2 bln in North Carolina plant in biopharma expansion

UPDATE 1-Fujifilm to invest $1.2 bln in North Carolina plant in biopharma expansion Adds Nikkei report on overall biopharma investment plan, paragraphs 3-4 TOKYO, April 12 (Reuters) - Japan's Fujifilm 4901.T will invest $1.2 billion to expand its North Carolina plant as part of its plans to expand biopharmaceutical contract manufacturing businesses in the United States and Europe, the company said on Thursday.
L

Biotech Firm NeuroSense Collaborates With Lonza To Identify Exosome-based Biomarkers

BRIEF-Biotech Firm NeuroSense Collaborates With Lonza To Identify Exosome-based Biomarkers April 9 (Reuters) - Lonza and NeuroSense Therapeutics: NEUROSENSE THERAPEUTICS: COLLABORATION WITH LONZA TO EVALUATE BIOLOGICAL CHANGES OCCURRING IN PEOPLE WITH NEURODEGENERATIVE DISEASES, INCLUDING ALS Source text for Eikon: ID:nPn1rPMXFa
L

Essilorluxottica, Remy Cointreau, Scout24

EUROPE RESEARCH ROUNDUP-Essilorluxottica, Remy Cointreau, Scout24 April 9 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Essilorluxottica, Remy Cointreau and Scout24, on Tuesday. HIGHLIGHTS * Burberry BRBY.L : Bernstein cuts target price to 1384p from 1402p * Essilorluxottica SA ESLX.PA : HSBC cuts to hold from buy * Remy Cointreau RCOP.PA : Jefferies cuts target price to EUR 120 from EUR 130 * Renault RENA.PA : Barclays raises to
A
A
B
B
B
C
H
I
K
K
K
L
L
L
M
N
O
P
R
R
S
S
S
T
T
T
U
V
A
A
J
J
M

Swiss stocks - Factors to watch on April 9

Swiss stocks - Factors to watch on April 9 ZURICH/BERLIN, April 9 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: SWISS NATIONAL BANK SNBN.S The Swiss National Bank sees no need for a central bank digital currency (CBDC) to be issued to the general public, Chairman Thomas Jordan said on Monday. The bank's vice chairman is set to speak on interest rates, foreign exchange interventions and achieving price stability on Tuesday.
B
C
L
U

Air France, Deutsche Bank, FinecoBank

EUROPE RESEARCH ROUNDUP-Air France, Deutsche Bank, FinecoBank April 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air France, Deutsche Bank and FinecoBank, on Wednesday. HIGHLIGHTS * Air France-KLM AIRF.PA : JP Morgan cuts target price to EUR 9 from EUR 9.20 * Deutsche Bank AG DBKGn.DE : JP Morgan raises PT to EUR 15.20 from EUR 15 * FinecoBank FBK.MI : JP Morgan raises to overweight from neutral * Segro SGRO.L : Barclays raise
B
B
D
D
H
H
I
J
J
L
N
P
R
S
V
A
F

Europe set for mixed start

LIVE MARKETS-Europe set for mixed start Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EUROPE SET FOR MIXED START European shares were set for a mixed start on Wednesday, as traders assessed chances of fewer Fed rate cuts this year following strong data in the U.S.
L
R
R
S
S
F
I
S
U
G

European stocks dragged down by healthcare; German inflation data in focus

UPDATE 2-European stocks dragged down by healthcare; German inflation data in focus For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window German inflation eases to almost 3-year low SSAB's costly mill investment sends shares down Ionos rises after winning government contract STOXX 600 down 0.8% Updates with closing prices By Johann M Cherian and Ankika Biswas April 2 (Reuters) - European stocks made a downbeat start to the second quarter, pres
E
L
S
U
E
F
U
G



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.